哥伦比亚大学新研究设施提高了纽约大学在医学研究方面的领先地位

Irving Gift启动哥伦比亚大学奥杜邦生物医学科技园第三栋建筑的奠基仪式

2001年2月9日纽约，2001年2月9日 - 由于获得了2100万美元的礼物，这一建筑将于今年在哥伦比亚大学雄心勃勃的五楼复杂，奥杜邦生物医学科技园区的第三栋楼。欧文癌症研究中心为纽约市慈善家和食品分销执行赫伯特·欧文林某命名，将为癌症研究的哥伦比亚有用的实验室空间，并将扩大哥伦比亚的成长遗传计划。通过这份礼物，欧文先生成为哥伦比亚 - 长老会历史上最大的捐助者，为医疗中心提供了近6100万美元的捐助者。Audubon Park的第一栋建筑，被称为与哥伦比亚大学合作开发的Mary Woodard Lasker生物医学研究建筑，以及纽约市和纽约市，拥有15家生物技术公司。该设施位于哥伦比亚 - 长老会医疗中心，是新的初创生物技术和生物专业相关公司的孵化器，是努力帮助城市通过促进行业之间的合作来帮助城市吸引其多亿美元生物技术行业份额的思考和学术科学。哥伦比亚拥有超过270个主动许可合作与行业，是国家排名第一的大学，它来自技术转让活动。“As the home of the Irving Cancer Research Center, Audubon’s third building will be crucial to Columbia's goals as a great university in the world's greatest city," said Columbia President George Rupp. "This building, like those it joins, will also help foster the economic strength of this diverse and very lively community. The work we do here together will lead to the kinds of discoveries and scientific breakthroughs that people everywhere look to for a fuller and more enjoyable life. Columbia is proud to lead this effort.” “Biomedical research is one of the strongest areas of opportunity for attracting funding, founding new biotechnology companies, creating jobs, and stimulating the city’s economy, while simultaneously producing major new scientific discoveries that will lead to lifesaving treatments,” says Gerald Fischbach, M.D., Columbia University's Vice President for Health and Biomedical Sciences, Dean of the Faculty of Health Sciences, and Dean of the Faculty of Medicine. “The Irving Cancer Research Center is another way Columbia continues to expand its outreach to New York and into its own community.” The Audubon Biomedical Science and Technology Park will eventually consist of five academic and commercial research facilities. Audubon brings medical advances from the laboratory to the bedside through innovative biotechnology underlying new medical treatments, technologies, and therapies. As New York City’s only university-related research park—housing the only biotechnology business incubator in the city—Audubon supplies the structure and organization to facilitate developments in biotechnology that will ensure improved health care, while contributing to economic growth through the creation of private sector research collaborations and the generation of new biomedically related business. The creation of the Irving Cancer Research Center, a state-of-the-art building bringing basic scientists and clinicians working on cancer, genetics and cell biology together in one site, will encourage collaborative efforts, building on Columbia’s important contributions in medical research and treatment. The 13-story, approximately 300,000-gross-square-foot facility will cost $131 million. “Mr. Irving has been the Herbert Irving Comprehensive Cancer Center’s major benefactor, initially supporting state-of-the-art facilities for adults and children with cancer and now investing in the basic research of the cancer center. Research is the key to understanding how cancer develops and to identifying targets for interventions to cure or even prevent cancer,” says Karen Antman, M.D., Wu Professor of Medicine (Oncology) and director, Herbert Irving Comprehensive Cancer Center. A $10 million gift from Avon Products Foundation to Columbia University and the NewYork-Presbyterian Hospital will help the cancer center expand its breast cancer research and clinical care. A portion of the gift will be used to support screening and comprehensive breast cancer care for indigent women in northern Manhattan. A comprehensive breast cancer screening facility and research laboratories will be located in the new building. The new building is designed by Davis Brody Bond and will sit east of Columbia-Presbyterian Medical Center on St. Nicholas Avenue between 166th and 167th streets in the Washington Heights section of Manhattan. The building features nine floors of research space, underground parking, and clinical facilities. Occupancy of the building will begin in the spring of 2003.

＃＃＃